Zura Bio Limited Warrants
ZURAW
ZURAW was delisted on the 27th of August, 2024.
13 hedge funds and large institutions have $682K invested in Zura Bio Limited Warrants in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 7 closing their positions.
19% less funds holding
Funds holding: 16 → 13 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
73% less capital invested
Capital invested by funds: $2.56M → $682K (-$1.87M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$20.2K |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$14.2K |
| 3 |
Walleye Trading
New York
|
+$11.3K |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$9.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$81K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$73.8K |
| 3 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$63.4K |
| 4 |
ICM
Ionic Capital Management
New York
|
-$30.9K |
| 5 |
AGC
Angelo Gordon & Co
New York
|
-$26.5K |
ZURAW Hedge Fund Activity: Q2 2023 in Review
13 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Zura Bio Limited Warrants (ZURAW) for Q2 2023, worth a combined $682K — down 73% from $2.56M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ZURAW and 4 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 0 added.
The largest buyer was Walleye Capital, opening a new position worth an estimated $20.2K. The largest seller was Shaolin Capital Management, exiting entirely with an estimated $81K sold.
- 13 institutional investors held Zura Bio Limited Warrants (ZURAW) as of Q2 2023, down from 16 in Q1 2023.
- Funds reported $682K of Zura Bio Limited Warrants stock for Q2 2023, down 73% quarter-over-quarter.
- 4 funds opened new Zura Bio Limited Warrants positions in Q2 2023 and 7 closed out, a net change of -3 holders.
- The largest Zura Bio Limited Warrants buyer in Q2 2023 was Walleye Capital, an estimated $20.2K added.
- The largest Zura Bio Limited Warrants seller in Q2 2023 was Shaolin Capital Management, an estimated $81K sold.
Based on aggregated 13F filings for Q2 2023.